# IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease

> **NCT04849325** · NA · UNKNOWN · sponsor: **Biotyx Medical (Shenzhen) Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Critical Limb Ischemia (CLI)

## Interventions

- **DEVICE:** Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- **DEVICE:** Percutaneous Transluminal Angioplasty (PTA) Device

## Key facts

- **NCT ID:** NCT04849325
- **Lead sponsor:** Biotyx Medical (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-09
- **Primary completion:** 2024-04
- **Final completion:** 2024-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04849325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04849325, "IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04849325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*